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MJA practice essentials  paediatrics
tions. Osler outlined the clinical effects of upper-ai
tion in 1892, but it is only in the past 40 years
systematic evaluation of paediatric obstructive sleep
drome (OSAS) has been ndertaken.
Prevalence and pathophysiology
The consensus view is that OSAS affects about 3%MJA • Volume 182 NumABSTRACT
• Always take a history of snoring and sleep disturbance when 
reviewing children in primary care, as there is evidence that 
episodes of hypoxia and arousal during sleep may result in 
deficits in memory, attention and behaviour, in addition to the 
well known sequelae of growth failure, developmental delay 
and cor pulmonale. Check for changes in behaviour affecting 
school progress.
• To investigate for possible obstructive sleep apnoea 
syndrome (OSAS), clinical examination, lateral neck x-ray 
(adenoidal hypertrophy) and overnight oximetry (desaturation 
episodes) are useful screening tests, but oximetry is best used 
in conjunction with polysomnography. A negative oximetry 
test does not exclude OSAS.
• Polysomnography is the best method for detecting and 
assessing the severity of OSAS in children, and is especially 
helpful for prioritising treatment and evaluating the risk of 
perioperative complications of adenotonsillectomy.
• Adenotonsillectomy is thought to “cure” (ie, symptoms 
disappear and overnight respiratory parameters are 
corrected) in about 80% of children with OSAS. The remaining 
20% need ongoing evaluation and treatment.
• Further research is needed to determine the “true” 
prevalence of OSAS; what degrees of severity of upper-airway 
obstruction lead to morbidity requiring treatment; and 
whether the deficits in neurocognitive function associated 
MJA 2005; 182: 419–423
with sleep-disordered breathing are fully correctable.Obstructive sleep apnoea syndrome is common and is associated with significant childhood morbiditieslth
in 
tivA ough Charles Dickens (in The Pickwick Papers published1836) is credited with the first description of obstruc-e sleep apnoea in an overweight boy called Joe, the





with 8%–12% snoring most nights.1,2 The peak prevalence occurs
between the ages of 2 and 8 years, when lymphoid enlargement
relative to upper-airway size is at its peak. However, upper-airway
obstruction during sleep should not be attributed solely to large
tonsils and adenoids. In fact, in many children they do not cause
significant obstruction, and evidence to date suggests a poor
correlation between tonsillar size and risk of OSAS.3 Other factors
that may modulate the risk of obstruction include altered upper-
airway tone, midface hypoplasia, allergic rhinitis, obesity and
genetic factors.4 Therefore, finding large tonsils in a child who
snores is not prima facie evidence of significant upper-airway
obstruction during sleep.
Morbidity
Severe upper-airway obstruction in children is known to result in
developmental delay, growth failure and cor pulmonale. What is less
well appreciated are the more recently identified morbidities.5,6
Over the past 20 years, an extensive body of literature has detailed
the effects of adult OSAS on daytime functioning. The areas affected
include verbal and non-verbal intelligence, memory, attention,
concentration, and executive functioning (ie, flexible analytical and
problem-solving ability) and psychosocial functioning.7
The potential for similar effects in children was largely unstud-
ied until a decade ago. There is now mounting evidence that
disruption of children’s sleep architecture (ie, the normal pattern
and sequence of stages of sleep) by repetitive episodes of hypoxia
and arousal may result in similar deficits.8 The behavioural aspects
most consistently reported include aggression, hyperactivity, inat-
tention, anxiety and shyness, while learning, memory and execu-
tive functioning are the neurocognitive areas most affected.9 A
direct relationship between the severity of OSAS in children and
the resultant neurocognitive deficits has also been demonstrated.8
Areas of ongoing research in children include the effect of upper-
airway obstruction on cardiovascular function (including systemic
hypertension) and metabolic dysfunction.
The more controversial issue is that of snoring without signifi-
cant changes in blood gas levels (primary snoring). This results
from vibration of the soft tissues of the upper airway, and implies
some degree of obstruction, albeit mild. Recent studies suggest
that primary snoring may not be as innocuous as previously
thought, with learning, neurocognitive and behavioural deficits
being described in snoring children.6,10 For example, continuous
snoring without intermittent hypoxia was found to be significantlyber 8 • 18 April 2005 419
MJA PRACTICE ESSENTIALS –  PAEDIATRICSassociated with poor academic performance in mathematics (odds
ratio [OR], 3.3), science (OR, 2.9), and spelling (OR, 4.5).10 The
cause was postulated to be fragmentation of sleep architecture,
although the authors did include in their analyses some children
with what would be considered mild hypoxia.
Clinical evaluation of snoring in children
It is clear from the data of several studies that primary snoring
cannot be confidently distinguished from OSAS on clinical history
alone.11,12 While assessment is more straightforward in children
with symptoms suggestive of severe obstruction, or in those with
conditions that predispose to OSAS (ie, Pierre Robin syndrome,
craniofacial syndromes or Down’s syndrome), most children with
OSAS fall into the less severe category.
Features in the clinical history that can be helpful in deciding
which children need surgery are listed in Box 1. Given that
adenotonsillectomy carries a risk of morbidity, and even mortality,
and that it costs about $40 million per year for adenotonsillecto-
mies on 1% of Australian children, there is an imperative to target
appropriate children for surgery.
On physical examination, adenoidal hypertrophy is suggested
by a hyponasal voice and evidence of daytime upper-airway
obstruction (eg, mouth breathing), while a muffled voice may
result from tonsillar enlargement. Failure to thrive may occur in
younger children, especially those with more severe obstruction,
and growth parameters should be plotted.
In addition to the length of the soft palate, and the size of the
tongue and oropharyngeal space, the tonsils and facial structure
should always be assessed. Nasal patency should be checked,
midface hypoplasia or micrognathia excluded, and a loud second
heart sound (suggestive of increased right-heart pressure) ruled
out. The presence of systemic hypertension and alterations in
chest-wall shape should also be evaluated, the latter suggesting
increased respiratory effort.
Investigations (Box 2)
Lateral x-ray of the neck (Box 3)
This provides useful information about the size of the adenoids
and the postnasal space. Even if the postnasal space is patent while
awake, its patency may diminish significantly during sleep, espe-
cially during rapid-eye-movement sleep when muscle tone is at its
nadir.
Overnight oximetry
This is a useful screening test because it is relatively simple to
perform, is widely available, and has a positive predictive value of
greater than 90%.13 However, its limitations as a diagnostic tool
need to be highlighted. In a recent study of a cohort of 349
children referred for assessment of snoring to a tertiary sleep
laboratory, screening oximetry had a negative predictive value of
only 47% when compared with polysomnography.13 Therefore,
negative findings can not be used to confidently exclude OSAS.
Another important factor is that different types of oximeters may
have varying performance characteristics, especially with regard to
averaging times and movement artefact. Thus, the presence and
severity of desaturation episodes may vary according to the specific
type of equipment used in the study. Furthermore, oximeters with
long averaging times, or algorithms designed to automatically
remove movement artefact, are more likely to record false-negative
results.
Polysomnography
Polysomnography is currently the gold standard for the detection
and assessment of the severity of OSAS in children.14,15 Polysomno-
graphy is a simultaneous recording of multiple physiological
parameters related to sleep and wakefulness (brain activity, eye
movements, muscle activity, heartbeat, blood oxygen levels and
respiration). Although polysomnography is often labelled as an
expensive procedure, it is not significantly more expensive than
other paediatric investigations, such as echocardiography. How-
1 Symptoms of obstructive sleep apnoea syndrome 
suggesting the need for adenotonsillectomy
Snoring and:
• Observed apnoea during sleep
• Struggling to breathe during sleep. Parents report that they shake 
the child to prompt breathing during sleep
• Parental anxiety, resulting in observing the child during sleep
• Unusual sleeping positions (eg, the “sword swallower” position 
with neck extended), restless sleep
• Slow to waken in the morning, tiredness on waking, 
hypersomnolence
• Impairment in memory, attention and behaviour
2 Flow chart of diagnosis and treatment of 
childhood OSAS
Childhood snoring
Lateral x-ray of neck and oximetry ? Primary snoring*
Positive findings Negative findings, but symptoms continue
Polysomnography
Positive findings Negative findings
Symptoms suggestive of OSAS
• Observed apnoea during sleep, causing 
parental anxiety
• Tiredness on waking, hypersomnolence
•  Impairment in memory, attention, 
behaviour and school progress
No symptoms of 
sleep apnoea 
Adenotonsillectomy
Follow-up and monitor 
(if OSAS was severe before surgery)
OSAS = obstructive sleep apnoea syndrome
*Monitor symptoms especially over winter and, if in doubt, perform oximetry
  
Follow-up if 
symptoms persist420 MJA • Volume 182 Number 8 • 18 April 2005
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sleep facilities in Australia.
Deciding which children need treatment for OSAS
As new research reveals significant morbidity, such as learning
deficits, potentially associated with primary snoring,6 the critical
cut-off level for treatment of childhood OSAS is regularly being
reviewed. Many clinicians screen children with overnight oximetry
if they have a history suggestive of OSAS. Children with abnormal
oximetry findings16 are referred for adenotonsillectomy. If the
oximetry findings are normal and the clinical history is suggestive
of OSAS, a polysomnogram will delineate the degree of upper-
airway obstruction. Polysomnography is especially helpful for
evaluating the risk of perioperative complications of adenotonsil-
lectomy in high-risk children (see section on Adenotonsillec-
tomy).
In children undergoing polysomnography, the current consen-
sus is that those with an obstructive apnoea–hypopnoea index of
more than five events per hour should be referred for adenotonsil-
lectomy, while surgical treatment is generally considered optional
for those with an apnoea–hypopnoea index of three to five per
hour. The latter group require ongoing clinical monitoring, with
the recommendation for or against surgery more likely to be
modified by the clinical history and physical findings.
Important issues that will improve the assessment of children for
surgery include standardising the analysis and interpretation of
paediatric sleep studies,14 and including factors other than just the
obstructive apnoea–hypopnoea index, as it can be difficult to
capture the severity of OSAS if interpretation is confined to a
simple score. Children have a predisposition to long periods of
obstructive hypoventilation rather than discrete apnoeas. This
means that cut-off levels for apnoea–hypopnoea indices that reflect




Adenotonsillectomy is the most appropriate therapy for most
children with OSAS, and may significantly reduce their behav-
ioural, learning and neurocognitive deficits.17,18 In a cohort of 297
first graders who were performing poorly academically, Gozal
found a 6- to 9-fold increase in the prevalence of OSAS. Adenoton-
sillectomy in the children who had OSAS resulted in a significant
improvement in their academic performance in the following
year,5 but there was no such improvement in those with OSAS
whose parents declined treatment.
Lipton and Gozal, in a recent extensive review of the outcomes
of adenotonsillectomy,19 reported the cumulative “cure” rate to be
about 80%. (“Cure” is disappearance of symptoms and normalisa-
tion of overnight respiratory parameters.) They acknowledged that
studies published to date are generally from tertiary referral centres
and therefore more likely to include children with coexisting
morbidities or underlying abnormalities. Outcomes in non-tertiary
settings have not been well studied.20
The same review found morbidity rates of 18%–34% in chil-
dren with OSAS having adenotonsillectomy,19 suggesting that the
cost–benefit ratio for individual children needs to be carefully
assessed. Complications that can occur in the postoperative period
include upper-airway obstruction secondary to oedema, immedi-
ate or delayed haemorrhage, and pulmonary oedema. The risk of
postoperative complications is highest in young children (ie,
younger than 3 years) and those with severe OSAS (especially
when combined with failure to thrive, right ventricular hypertro-
phy, and a history of prematurity), and in those with craniofacial
abnormalities, especially midface hypoplasia.18 It is important that
surgery in children who are at increased risk of postoperative
complications is undertaken in units with specialised intensive
care facilities.
Despite this, as the tonsils and adenoids represent a space-
occupying lesion in the oropharynx, and the site of the adenoton-
sillar tissue is the commonest location of airway occlusion,21
adenotonsillectomy (rather than just the removal of the tonsils or
adenoids) is the treatment of choice for childhood OSAS.
Other surgical strategies for complex OSAS
In children with “complex OSAS” (eg, Down’s syndrome, cranio-
facial syndromes) tailored surgical solutions may also be under-
taken. These include a variety of surgical techniques such as
mandibular advancement (distraction) in Treacher Collins syn-
drome, uvulopalatopharyngoplasty in cerebral palsy, and partial
glossectomy in Beckwith syndrome. A combination of surgical
techniques may be required to alleviate OSAS. Pre- and postopera-
tive polysomnography is required to objectively confirm the
outcomes.
3 Lateral neck x-ray in a child with obstructive sleep 
apnoea syndromeMJA • Volume 182 Number 8 • 18 April 2005 421
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Data on the usefulness of nasal steroids in childhood upper-airway
obstruction is limited. In a cohort of 25 children with moderate
OSAS, nasal steroids (fluticasone) for a 6-week period reduced
mean overnight oxygen desaturation episodes by over 50%;
however, by the conclusion of the study, 46% of those treated with
nasal steroids required adenotonsillectomy.22 The role of this
therapy is yet to be defined, but some authorities argue that a trial
of nasal steroid administration may be worthwhile in children with
less severe OSAS. The optimal duration of treatment is not known.
Continuous positive airway pressure (CPAP)
Positive pressure support is usually reserved for children with
persistent OSAS despite adenotonsillectomy, or for those with
specific contraindications to surgery. Unlike adenotonsillectomy, it
is not curative and may need to be used for many years. Treatment
success depends on the expertise of an experienced “sleep team”
that adjusts an appropriate mask to fit the child and optimise
comfort, avoiding complications such as air leaks or pressure
sores. The requisite pressure to correct upper-airway obstruction
during sleep is titrated during polysomnography.
This method of treatment has been successful in children from
infancy to teenage years, but depends in large measure on
appropriate training of parents and children23 and regular follow-
up. In children who have difficulty in breathing against the CPAP,
bilevel ventilation is often successful. Bilevel ventilation allows
positive pressure support on inspiration, which, unlike with CPAP,
falls on expiration. Some concern exists regarding the potential for
a CPAP mask, used from an early age, to cause midface hypoplasia,
although the evidence is limited.24
Overnight oxygen supplementation
Although supplemental oxygen abolishes desaturation episodes
associated with OSAS, it does not treat the underlying obstruction.
In addition, oxygen therapy can exacerbate hypercarbia. Despite
these caveats, it may be useful in some children in whom other
treatments have not been successful; for example, a child may still
have symptoms of ongoing upper-airway obstruction after ade-
notonsillectomy, and may not tolerate CPAP.
Conclusions
What we now know
• OSAS is common and is associated with significant childhood
morbidities. The most frequent presenting symptom is snoring.
• Adenotonsillectomy is the most appropriate therapy in most
children with OSAS, and OSAS is a clear (and increasingly
common) basis for undertaking such surgery. However, the indica-
tions for surgery are now more stringent because of the risk of
operative complications.
• Accurate diagnosis of the presence and severity of upper-airway
obstruction is essential.
• The gold standard for diagnosing OSAS is polysomnography,
which can provide valuable information regarding the need for
surgery and risks likely to be associated with surgery.
Case study — a 5-year-old boy with obstructive sleep 
apnoea syndrome (OSAS)
A mother brings her 5-year-old son to you, as she is concerned 
about his loud snoring. He has been snoring for 2 years, but it is 
gradually becoming louder. Although she is unaware of whether or 
not her son has obstructive apnoeas, she is anxious about his 
breathing during sleep. She often sits up to watch him breathe 
before retiring herself. The mother reports that the boy’s teacher at 
school says that her son has a poor concentration span and is easily 
distracted in class. Both the father and grandfather snore loudly, but 
neither has sought medical advice or investigation.
Management
• On examination, you find that the boy has relatively small tonsils 
and you initially reassure his mother. However, as his symptoms 
persist, you refer him to a paediatric respiratory physician.
• An overnight home oximetry study shows only mild desaturations 
that appear to be associated with movement.
• A lateral x-ray of the neck confirms adenoidal hypertrophy but a 
patent postnasal space.
• A polysomnogram shows an obstructive respiratory disturbance 
index of nine per hour.
• Based on the data from the polysomnogram, the boy undergoes 
adenotonsillectomy.
After the operation, the boy’s snoring resolves, his behaviour and 
concentration improve, and his mother describes him as a “different 
boy”.
At the 1-year follow-up, the boy’s mother reports that his snoring has 
returned. You resume frequent clinical monitoring, and 
subsequently refer him for repeat polysomnography, as his history 
once again suggests the presence of OSAS.
If polysomnography confirms that OSAS has returned, and a lateral 
neck x-ray shows that his adenoids have not regrown, the use of 
night-time continuous positive airway pressure (CPAP) support will 
be considered.
Evidence-based practice tips
• Primary snoring cannot be confidently distinguished from 
obstructive sleep apnoea syndrome on clinical history alone 
(III-2).11,12
• The risk of upper airway obstruction does not depend on the 
size of the tonsils or adenoids per se, but on their relative size 
compared with that of the upper airway (III-2).3
• Polysomnography is the gold standard method of detecting and 
assessing the severity of obstructive sleep apnoea syndrome in 
children (III-2).14,15
• Adenotonsillectomy is the treatment of choice in children with 
proven obstructive sleep apnoea syndrome (III-2).17,18
• There is a higher risk of perioperative problems in children who 
have severe obstructive sleep apnoea syndrome, comorbid 
medical conditions such as midface hypoplasia, or are younger 
than 3 years of age (III-2).19
• Not all children with obstructive sleep apnoea syndrome are 
“cured” by adenotonsillectomy. About 20% will need ongoing 
evaluation and, possibly, further treatment (III-2).19
Levels of evidence (I–IV) are derived from the National Health and Medical 
Research Council’s system for assessing evidence.25422 MJA • Volume 182 Number 8 • 18 April 2005
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ingly important, as we recognise that it is not uncommon for
obstruction to persist, and as the consequences of untreated
disease in children are better defined.
What we still need to find out
• What is the natural history of snoring and what are the effects
of treatment for individual children over the whole age range?
• What is the “true” prevalence of OSAS, as the gold standard
method of diagnosing it — polysomnography — is an expensive
and time-consuming tool for large-scale epidemiological studies?
• What degrees of severity of upper-airway obstruction lead to
morbidity requiring treatment?
• What is the cost–benefit ratio of adenotonsillectomy in individ-
ual children?
• Are the deficits in neurocognitive function associated with
sleep-disordered breathing fully correctable?
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